Norris Medicines Ltd.
BSE: NORRIS · Trading & Distributors · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 157 companies in Trading & Distributors (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹22 cr (FY26): borrowings are higher by ₹22 cr.
- Operating profit covered interest -0.3x in the last 12 months.
- Net loss in 4 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹14.31 on 2026-10-26: -28.7% from the 52-week high, +19.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 3 | 1 | 3 | 3 | 1 | 1 |
| EBITDA | 0 | -0 | -1 | 1 | 0 | -0 |
| OPM % | 2.6% | -6.8% | -17.1% | 29.1% | 22.0% | -30.4% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -0 | -0 | -1 | 1 | 0 | -0 |
| EPS (₹) | 0.23 | 0.62 | 2.08 | 0.70 | 0.05 | 0.80 |
| Revenue YoY | -48.2% | -37.0% | ||||
| Profit YoY | – | – |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 9 | 8 | 6 | 6 | 8 | 9 |
| EBITDA | -0 | 1 | -0 | -0 | 1 | 0 |
| Net profit | -3 | -2 | -1 | -1 | -0 | -1 |
| EPS (₹) | -3.26 | -1.75 | -1.19 | 1.24 | 0.28 | 3.63 |
| Revenue growth | -11.4% | -32.5% | +3.2% | +39.7% | – | |
| Profit growth | – | – | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -0.9% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -8.7% (2y) | -10.7% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | -15 | -15 |
| Borrowings | 22 | 22 |
| Cash & equivalents | 0 | 0 |
| Total assets | 14 | 13 |
| Fixed assets | 5 | 5 |
| Investments | 0 | 0 |
| Receivables | 1 | 1 |
| Inventory | 4 | 4 |
| Payables | 3 | 3 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 0 | 1 |
| Cash from investing | -1 | -0 |
| Cash from financing | -0 | -1 |
| Capex | 0 | 0 |
| Free cash flow | 0 | 1 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 8.3% | 1.9% |
| ROCE % | -11.0% | 3.4% |
| Debtor days | 88 | 53 |
| Inventory days | 437 | 338 |
| Payable days | 320 | 222 |
| Cash conversion cycle (days) | 205 | 169 |
| Working capital days | -239 | -167 |
Peers in Trading & Distributors
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| REDINGTON | ₹28,671 cr | 16.9x | 2.8x | 18.0% | 18.4% | 1.9% | +14.5% | 1.85% |
| MMTC | ₹7,599 cr | 17.0x | 3.6x | 23.4% | 25.6% | 10,805.5% | -90.1% | – |
| MSTCLTD | ₹4,097 cr | 17.5x | 4.5x | 28.5% | 30.1% | 61.1% | -20.0% | 1.30% |
| CNL | ₹1,607 cr | 24.7x | 4.4x | 22.4% | 16.3% | 3.6% | +25.2% | 0.05% |
| BNAGROCHEM | ₹1,267 cr | 45.5x | 2.7x | 4.0% | 0.7% | -0.5% | – | – |
| YSL | ₹757 cr | 8.3x | 0.6x | 7.1% | 0.3% | 2.1% | +0.3% | 2.03% |
| SHIVAUM | ₹738 cr | 64.9x | 6.1x | 10.2% | 11.3% | 3.1% | – | – |
| STCINDIA | ₹594 cr | 0.9x | 1.0x | 228.5% | 108.2% | – | – | – |
| PERVASIVE | ₹587 cr | 0.1x | 6.5x | -0.2% | -0.1% | -0.9% | – | – |
| NORRIS | ₹11 cr | 3.9x | – | – | -2.8% | 4.2% | -0.9% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Services |
| Industry | Trading & Distributors |
| Sub-industry | Trading & Distributors |
| Symbol | NORRIS |
| BSE code | 524414 |
| ISIN | INE744C01029 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.